Literature DB >> 26868381

Draft Genome Sequences of Two Methicillin-Resistant Clinical Staphylococcus aureus Isolates.

Saeed Khan1, Kidon Sung2, Saira Iram3, Mohamed Nawaz2, Joshua Xu4, Bernard Marasa5.   

Abstract

Here, we report the draft genome sequences of two methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates, hospital-associated perirectal isolate 32S (ST 239) from a colitis tracheostomy patient and community-associated MRSA isolate 42S (ST 772) from a hepatic-splenomegaly patient in Rawalpindi, Pakistan.
Copyright © 2016 Khan et al.

Entities:  

Year:  2016        PMID: 26868381      PMCID: PMC4751305          DOI: 10.1128/genomeA.01396-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Staphylococcus aureus is one of the leading human pathogens that causes a broad variety of infections, ranging from minor skin infections to life-threatening conditions, such as endocarditis, pneumonia, toxic shock syndrome, and bloodstream infections (1–3). Molecular characterization of the virulence and antimicrobial resistance gene profiles and the draft genome sequences of methicillin-resistant S. aureus (MRSA) isolates will enhance the understanding of their evolution and aid in rapid diagnosis, detection, and development of better therapeutic intervention strategies. The isolates described here were highly resistant to oxacillin (MIC, 512 mg/L) and ciprofloxacin (MIC, >256 mg/L), and also exhibited resistance to ampicillin, tetracycline, penicillin, erythromycin, gentamicin, and kanamycin. Sequence analysis of the quinolone resistance determinant region of the target gene gyrA indicated a double point mutation (S84L and G106D) in 32S and a single point mutation in 42S (S84L). The grlA gene exhibited E84G mutation in 32S and S80Y in 42S. RT-qPCR analysis of the efflux pump genes, norA, norB, norC, and mdeA, indicated an increased efflux pump expression in these isolates (4). Both of the isolates were positive for staphylococcal cassette chromosome type SCCmec III and harbored various toxin genes (eta, sea, seb, sec, hla, hlb, hld, hlg, pvl, lukS, lukF, lukM, lukE-D, sed, see, seg, seh, and tst), adhesin genes (ebpS, bbp, cna, clfA, clfB, fnbA, fnbB, map-eap, and spa), and virulence genes (chp, ica, cfb, and v8). Multilocus sequence typing (MLST) as described in Enright et al. (5) indicated an ST 239 profile for 32S and ST 772 for 42S. The sequence analysis of the 3′ coding region X of the spa gene with the online spa-typing program (http://spatyper.fortinbras.us) revealed the spa type t030 for 32S and t5414 for 42S. The genomic DNAs from S. aureus were extracted using a Master Pure Gram-positive DNA purification kit (Epicentre Biotechnologies). The library was prepared using a TruSeq DNA library preparation kit (Illumina) and the TruSeq paired-end cluster kit was used for the DNA preparation and cluster generation. The Illumina HiSeq 2500 system was used for sequencing. CLC Genomics Workbench 6.5.1 (Qiagen) was used for the de novo assembly of high-quality 100 bp paired-end reads and further genome annotation was performed using an annotation method GeneMarkS+ in the NCBI Prokaryotic Genome Annotation Pipeline (6). The draft genome sequence of S. aureus 32S is 2,943,897 bp in length which is distributed in 118 contigs (average coverage, 20.0×) with 3,082 genes, 2,912 CDs, 110 pseudo genes, 37 frameshifted genes, 3 rRNAs (5S,16S, 23S), and 56 tRNAs. The draft genome sequence of S. aureus 42S has 32.7% G+C content, is 2,766,469 bp in length which is distributed in 86 contigs (average coverage, 50×) with 2,816 genes, 35 frame-shifted genes, 63 pseudo genes, 2,692 CDs, 6 rRNAs (5S,16S, 23S), and 55 tRNAs.

Nucleotide sequence accession numbers.

This whole-genome shotgun project was deposited at DDBJ/EMBL/GenBank under the accession numbers JTJX00000000 and JTFJ00000000 for 32S and 42S, respectively. The versions described in this paper are versions JTJX02000000 and JTFJ01000000.
  5 in total

1.  Toward an online repository of Standard Operating Procedures (SOPs) for (meta)genomic annotation.

Authors:  Samuel V Angiuoli; Aaron Gussman; William Klimke; Guy Cochrane; Dawn Field; George Garrity; Chinnappa D Kodira; Nikos Kyrpides; Ramana Madupu; Victor Markowitz; Tatiana Tatusova; Nick Thomson; Owen White
Journal:  OMICS       Date:  2008-06

Review 2.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

3.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

Review 4.  Pathogenesis of methicillin-resistant Staphylococcus aureus infection.

Authors:  Rachel J Gordon; Franklin D Lowy
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

5.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.

Authors:  M C Enright; N P Day; C E Davies; S J Peacock; B G Spratt
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

  5 in total
  3 in total

1.  Genotyping of methicillin-resistant Staphylococcus aureus from sepsis patients in Pakistan and detection of antibodies against staphylococcal virulence factors.

Authors:  Stefan Monecke; Muhammad Ali Syed; Mushtaq Ahmad Khan; Shehzad Ahmed; Sadia Tabassum; Darius Gawlik; Elke Müller; Annett Reissig; Sascha D Braun; Ralf Ehricht
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-03       Impact factor: 3.267

2.  Anticancer L-Asparaginase and Phytoactive Compounds From Plant Solanum nigrum Against MDR (Methicillindrug resistant) Staphylococcus aureus and Fungal Isolates.

Authors:  Ambreen Aisha; Saba Zahra; Imtiaz M Tahir; Asim Hussain; Naheed Bano; Alishbah Roobi; Nadia Afsheen; Yasir Saleem
Journal:  Dose Response       Date:  2022-04-27       Impact factor: 2.623

3.  Nasopharyngeal carriage, spa types and antibiotic susceptibility profiles of Staphylococcus aureus from healthy children less than 5 years in Eastern Uganda.

Authors:  David Patrick Kateete; Benon B Asiimwe; Raymond Mayanja; Brian Mujuni; Freddie Bwanga; Christine F Najjuka; Karin Källander; Elizeus Rutebemberwa
Journal:  BMC Infect Dis       Date:  2019-12-02       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.